SurModics Pharmaceuticals and Genzyme Pharmaceuticals Collaboration
Genzyme Pharmaceuticals, a business unit of Genzyme Corporation, and SurModics Pharmaceuticals, a SurModics company, have a broad collaboration to develop novel drug delivery solutions, with an initial focus in Design for Peptide DeliverySM. The partnership offers customized solutions for parenteral formulations by combining expertise in peptide delivery, peptide synthesis, and drug delivery technologies.
Rather than promoting a specific technology, the SurModics Pharmaceuticals-Genzyme Pharmaceuticals Collaboration offers customers a solution-oriented approach to peptide formulation through synergistic capabilities and technologies, depending on the peptide and the customer's target drug profile. Customers will also benefit from enhanced capabilities and services such as research-scale peptide synthesis for backbone and side chain modifications, evaluation of available drug delivery technologies, large-scale peptide drug substance production, formulation feasibility studies and development of microencapsulation processes, drug excipients manufacturing (phospholipids, polymers and biomaterials), drug product formulation, and manufacturing of clinical supplies and final drug delivery product.